PO5

(2S)-1-(dimethylamino)-3-(4-{[4-(6-morpholin-4-ylpyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-yl]amino}phenoxy)propan-2-ol

Created:	2008-09-17
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where PO5 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	66
Chiral Atom Count	1
Bond Count	70
Aromatic Bond Count	23

2D diagram of PO5

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2S)-1-(dimethylamino)-3-(4-{[4-(6-morpholin-4-ylpyrazolo[1,5-b]pyridazin-3-yl)pyrimidin-2-yl]amino}phenoxy)propan-2-ol
Systematic Name (OpenEye OEToolkits)	(2S)-1-dimethylamino-3-[4-[[4-(6-morpholin-4-ylpyrazolo[5,1-f]pyridazin-3-yl)pyrimidin-2-yl]amino]phenoxy]propan-2-ol
Formula	C₂₅ H₃₀ N₈ O₃
Molecular Weight	490.558
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	n4n3ncc(c1nc(ncc1)Nc2ccc(OCC(O)CN(C)C)cc2)c3ccc4N5CCOCC5
SMILES	CACTVS	3.341	CN(C)C[CH](O)COc1ccc(Nc2nccc(n2)c3cnn4nc(ccc34)N5CCOCC5)cc1
SMILES	OpenEye OEToolkits	1.5.0	CN(C)CC(COc1ccc(cc1)Nc2nccc(n2)c3cnn4c3ccc(n4)N5CCOCC5)O
Canonical SMILES	CACTVS	3.341	CN(C)C[C@H](O)COc1ccc(Nc2nccc(n2)c3cnn4nc(ccc34)N5CCOCC5)cc1
Canonical SMILES	OpenEye OEToolkits	1.5.0	CN(C)C[C@@H](COc1ccc(cc1)Nc2nccc(n2)c3cnn4c3ccc(n4)N5CCOCC5)O
InChI	InChI	1.03	InChI=1S/C25H30N8O3/c1-31(2)16-19(34)17-36-20-5-3-18(4-6-20)28-25-26-10-9-22(29-25)21-15-27-33-23(21)7-8-24(30-33)32-11-13-35-14-12-32/h3-10,15,19,34H,11-14,16-17H2,1-2H3,(H,26,28,29)/t19-/m0/s1
InChIKey	InChI	1.03	GBRORGYPYNNDGL-IBGZPJMESA-N

Related Resource References

Resource Name	Reference
PubChem	44629729

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.